ITCMDBv1
Meta AnalysisID 7330

壬二酸与氢醌治疗黄褐斑的比较

CRD42023433925

Does azelaic acid superior to Hydroquinone in managing patients with Melasma?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
7330
Evidence Id
15888
Core Evidence Id
15888
Source Meta Analysis Id
7318
Herb2 Meta Analysis Id
HBMA007318
Crd Id
CRD42023433925
Title
Azelaic Acid versus Hydroquinone for Managing Patients with Melasma
Review Question
Does azelaic acid superior to Hydroquinone in managing patients with Melasma?
Study Type Included
RCTs (randomized controlled trials )
Condition Being Studied
Patients with Melasma (pigmented skin disorder)
Participant
Patients with Melasma
Animal
Human Disease Modelled
Intervention
Azelaic acid
Comparator Control
Hydroquinone
Main Outcome
Melasma Area Severity Index (MASI) Measures of effect Mean SD
Outcome Measure
Additional Outcome
Adverse events Measures of effect RR (risk ratio)
Study Method
Meta-analysis, Systematic review
Keyword
Dicarboxylic Acids; Humans; Hydroquinones; Melanosis; Orobanchaceae; azelaic acid; hydroquinone
Contact
Ebraheem Albazee [email protected]
Organisational Affiliation
Hashemite University
Funding Source
None Grant number(s) State the funder, grant or award number and the date of award None
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Egypt, Kuwait
Review Stage
Review Ongoing
First Submission Date
2023-06-09
Registration Date
2023-06-19
Anticipated Start Date
2023-05-29
Anticipated Completion Date
2023-08-01
Title Cn
壬二酸与氢醌治疗黄褐斑的比较
Title En
Azelaic Acid versus Hydroquinone for Managing Patients with Melasma
Bilingual Status
complete